Arrhythmias & electrophysiologyCohort study

Implantable loop recorders in patients with Brugada syndrome: the BruLoop study

Eur Heart JPublished

  • Multicentre cohort study
  • 18 international centres

Authors' conclusion

ILR detects arrhythmic events in nearly 30% of symptomatic BrS patients, leading to appropriate therapy in 70% of them. The most commonly detected arrhythmias are AAs and BAs, while VAs are detected only in 7% of cases.

Study context

Population
Patients with Brugada syndrome and implantable loop recorders (ILRs) (mean age 43.5 ± 15.9, 33.8% female, 74.1% symptomatic)
Participants
370 patients · 18 international centres
Outcome
Diagnostic yield of continuous rhythm monitoring by ILR (arrhythmic events)
Follow-up
Median 3 years

Main finding

As reported in the abstract

Arrhythmic event recorded, symptomatic patients

Any arrhythmic event

30.7%

Atrial arrhythmias

18.6%

Bradyarrhythmias

10.2%

Ventricular arrhythmias

7.3%

Observational data: associations, not effects.

Further findings

OutcomeHRP value
Independent predictors of arrhythmic events (multivariate analysis) — Presence of symptoms · multivariate analysis2.5P = 0.001
Independent predictors of arrhythmic events (multivariate analysis) — Age >50 years · multivariate analysis1.7P = 0.016
Predictor of VAs (multivariate analysis) · multivariate analysis9.0P < 0.001

Arrhythmic aetiology in patients with recurrent syncope

Arrhythmic aetiology
22.4%
Bradyarrhythmias (BAs) among arrhythmic causes
59.3%
Ventricular arrhythmias (VAs) among arrhythmic causes
25.0%
Atrial arrhythmias (AAs) among arrhythmic causes
15.6%

Therapy initiated after ILR findings

Drug therapy initiation
11.4%
Ablation procedure
10.9%
Pacemaker implantation
2.5%
Cardioverter-defibrillator implantation
8%

Original publication

Implantable loop recorders in patients with Brugada syndrome: the BruLoop study. Eur Heart J. Published 6 March 2024. doi:10.1093/eurheartj/ehae133

Summarised from the published abstract; every number is checked against it